Advancis Pharmaceutical Corp., of Germantown, Md., promoted Robert Low to vice president of finance and chief financial officer, and Robert Bannon to vice president of investor relations and corporate communications...Cabrellis Pharmaceuticals Corp., of San Diego, named Tracy Lawhon vice president of regulatory affairs and development operations

Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed to its medical and scientific advisory board Steven DeKosky, Rachelle Doody, Mary Sano, Lon Schneider, Leon Thal and Bengt Winblad

Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed to its medical and scientific advisory board Steven DeKosky, Rachelle Doody, Mary Sano, Lon Schneider, Leon Thal and Bengt Winblad

Oscient Pharmaceuticals Corp., of Waltham, Mass., appointed William Mattson to its board...Oxigene Inc., of Waltham, Mass., appointed Richard Chin president and CEO

and Antonio Gotto to its board and scientific advisory board...Aspreva Pharmaceuticals Corp., of Victoria, British Columbia, appointed Richard Jones senior vice president clinical and regulatory affairs...and Charles Sholtz vice president of intellectual property and legal affairs

Aspreva Pharmaceuticals Corp., of Victoria, British Columbia, appointed William Hunter to its board...BioSyntech Inc., of Laval, Quebec, appointed Rudy Huber and Joyce Tsang to its board

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Martin Williams vice president of business and commercial development and chief business officer...and Suresh Babu vice president of drug product development

Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed Tommy Thompson, Jim Artman, William McConville, Kevin Giblin, James Carney and Sheldon Goldberg to its board

Advancis Pharmaceutical Corp., of Germantown, Md., hired James Bruno as vice president of sales and Seung Baick as assistant product director...Lydon and Wendell Wierenga also joined the company’s board

Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed Joseph DeVeaugh-Geiss interim chief medical officer...Mary Haak-Frendscho vice president, preclinical research and development

Alliance Pharmaceutical Corp., of San Diego, appointed Jack DeFranco president and chief operating officer

Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed Jim Artman and William McConville to its board

Eximias Pharmaceutical Corp., of Berwyn, Pa., appointed Ruedi Waeger to its board...Galapagos NV, of Mechelen, Belgium, appointed Ferdinand Verdonck independent director, and Harrold van Barlinger dependent director

Eximias Pharmaceutical Corp., of Berwyn, Pa., appointed Gerard Kennealey senior vice president and chief medical officer...Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Tony Scullion full-time executive chairman

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Robert Terifay senior vice president, commercial development and strategy, and Stephen Gansler vice president, human resources

Eximias Pharmaceutical Corp., of Berwyn, Pa., appointed Jeff Randall chief financial officer, Gary Floyd vice president of operations, and John Bennett vice president of business development

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Robert Terifay senior vice president, commercial development and strategy, and Stephen Gansler vice president, human resources

Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Tony Scullion president, and David Lowe to its board

Alda Pharmaceuticals Corp., of Vancouver, British Columbia, appointed William McCoy to its board...Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed Sheldon Goldberg senior vice president of corporate development